Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants

Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants

We hypothesize that inhaled Furosemide will be an effective treatment in infants with acute bronchiolitis.

Inclusion Criteria:

• Age: 0-12 months.
• Infants who are otherwise healthy
• Infants with chronic lung disease of prematurity (BPD) will be included, but will be analyzed separately.
• Parents signed a written informed consent.

Exclusion Criteria:

• • Other previous or co-morbidity, specifically: respiratory (other than BPD, like Asthma or Cystic Fibrosis), cardiac or renal disease or anomaly.